---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-061649"
form_type: "8-K"
ticker: "HCTI"
cik: "0001839285"
company_name: "Healthcare Triangle, Inc."
filed_at: "2025-07-07T23:59:59+00:00"
generated_at: "2026-05-18T09:20:58.104045+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq Hearings Panel grants Healthcare Triangle continued listing with reverse stock split and bid price conditions

## Summary
- Nasdaq Hearings Panel granted Healthcare Triangle continued listing on July 2, 2025, finding compliance with shareholders' equity rule and declining delisting.
- Company must effect a reverse stock split by August 8, 2025 at a ratio sufficient to achieve long-term compliance with the bid price rule.
- By September 5, 2025, Healthcare Triangle must demonstrate compliance with the $1.00 minimum bid price for 20 consecutive trading days.
- A discretionary panel monitor will be imposed for one year after regaining compliance with the bid price rule.
- Chairman Dave Rosa expressed gratitude and optimism for executing strategic growth plan.

## SEC filing metadata
- accession: 0001213900-25-061649
- form_type: 8-K
- ticker: HCTI
- cik: 0001839285
- company_name: Healthcare Triangle, Inc.
- filed_at: 2025-07-07T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839285/000121390025061649/0001213900-25-061649-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839285/000121390025061649/ea0248240-8k_healthcare.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-061649
- JSON: https://secwatch.observer/filing/0001213900-25-061649.json
- Plain text: https://secwatch.observer/filing/0001213900-25-061649.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
